Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Cohn

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Oncogene|May 29, 1999
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cellsM Haber, S B Bordow, J Gilbert, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastomaM D Norris, S B Bordow, P S Haber, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2000
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group StudyC S Alvarado, W B London, A T Look, et al.
Epidemiology (Cambridge, Mass.)|January 4, 2001
Residential pesticide exposure and neuroblastomaJ L Daniels, A F Olshan, K Teschke, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Bone Marrow Transplantation|January 22, 2013
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1A E Seif, A Naranjo, D L Baker, et al.
British Journal of Cancer|June 3, 2015
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group studyL L Wang, R Teshiba, N Ikegaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group studyH M Katzenstein, L C Bowman, G M Brodeur, et al.
British Journal of Cancer|September 15, 2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectG Schleiermacher, V Mosseri, W B London, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Oncogene|May 29, 1999
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cellsM Haber, S B Bordow, J Gilbert, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastomaM D Norris, S B Bordow, P S Haber, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2000
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group StudyC S Alvarado, W B London, A T Look, et al.
Epidemiology (Cambridge, Mass.)|January 4, 2001
Residential pesticide exposure and neuroblastomaJ L Daniels, A F Olshan, K Teschke, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Bone Marrow Transplantation|January 22, 2013
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1A E Seif, A Naranjo, D L Baker, et al.
British Journal of Cancer|June 3, 2015
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group studyL L Wang, R Teshiba, N Ikegaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group studyH M Katzenstein, L C Bowman, G M Brodeur, et al.
British Journal of Cancer|September 15, 2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectG Schleiermacher, V Mosseri, W B London, et al.
Pageof 10